Cardinal Health Introduces Smart-Seal Surgical Mask
Cardinal Health announces the availability of its Smart-Seal surgical mask, designed to enhance fit and help reduce fog on eyewear. The mask is the companys latest addition to its facial protection portfolio and leverages the key design features of the companys Secure-Gard® mask while adding enhanced features of fit and fog protection.
The Smart-Seal surgical mask features a patent-pending, "cinch and hug" single-tie design that creates a custom seal around the wearers nose and mouth. The innovative design eliminates gaps between the wearers face and the mask, promoting proper use and helping to reduce contamination risks in the perioperative environment.
The Smart-Seal surgical mask features closed-cell foam and a fog-reducing vapor barrier. It also has a large chamber with two rows of sonic bonds that help keep the mask filter away from the wearers face and minimize distractions.
The Smart-Seal surgical mask provides the highest level of fluid-resistant protection at 160mmHg. In addition, the Smart-Seal surgical mask meets the highest level of bacteria filtration efficiency (BFE) and particulate filtration efficiency (PFE), with BFE equaling 99.9 percent and PFE equaling 99 percent.
"We developed the Smart-Seal surgical mask in direct response to customer indications that fogging was a problem," says Lisa Ashby, president of category management at Cardinal Health. "The Smart-Seal mask offers the next evolution in surgical mask protection, addressing not only fog and fit, but also providing the highest level of filtration and fluid resistance."
Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
